ERBB3 and gastric cancer: With respect to the adaptive response upon MET inhibition observed here, it is noteworthy that PI3K-AKT inhibition, which is a consequence of MET inhibition in MET-amplified gastric cancer cells, can induce HER3 upregulation in other tumor entities via a FOXO-dependent mechanism [27].